{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:50:27Z","timestamp":1781189427212,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jsat.2014.07.006","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T16:00:37Z","timestamp":1406131237000},"page":"8-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Misuse of atypical antipsychotics in conjunction with alcohol and other drugs of abuse"],"prefix":"10.1016","volume":"48","author":[{"given":"Tara","family":"Malekshahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Tioleco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahima","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee N.C.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Haller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2014.07.006_bb0105","series-title":"Fingertip Formulary","author":"Fingertip Formulary","year":"2011"},{"key":"10.1016\/j.jsat.2014.07.006_bb0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neubiorev.2009.11.003","article-title":"The role of antihistaminic effects in the misuse of quetiapine: A case report and review of the literature","volume":"34","author":"Fischer","year":"2010","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.jsat.2014.07.006_bb0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2431-13-187","article-title":"Acute dyskinesia, myoclonus, and akathisa in an adolescent male abusingquetiapine via nasal insufflation: A case study","volume":"13","author":"George","year":"2013","journal-title":"BMC Pediatrics"},{"key":"10.1016\/j.jsat.2014.07.006_bb0020","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1176\/appi.ajp.162.9.1755-a","article-title":"Intravenous quetiapine abuse","volume":"162","author":"Hussain","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2014.07.006_bb0025","series-title":"IBM SPSS Statistics for Windows, Version 21.0. [Computer software]","year":"2012"},{"key":"10.1016\/j.jsat.2014.07.006_bb0030","series-title":"The use of medicines in the United States: Review of 2010","author":"IMS Institute for Healthcare Informatics","year":"2011"},{"key":"10.1016\/j.jsat.2014.07.006_bb0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1744-6163.2008.00175.x","article-title":"Incarcerated care and quetiapine abuse","volume":"44","author":"Keltner","year":"2008","journal-title":"Perspectives in Psychiatric Care"},{"issue":"3","key":"10.1016\/j.jsat.2014.07.006_bb0060","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1530-0277.2011.01649.x","article-title":"A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients","volume":"36","author":"Litten","year":"2012","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.jsat.2014.07.006_bb0040","series-title":"Addiction Severity Index Composite Scores Manual","author":"McGahan","year":"1986"},{"issue":"5","key":"10.1016\/j.jsat.2014.07.006_bb0045","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/JCP.0b013e3182670648","article-title":"Characteristics of quetiapine misuse among clients of a community-based methadone maintenance program","volume":"32","author":"McLarnon","year":"2012","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jsat.2014.07.006_bb0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10550490500528316","article-title":"The Addiction Severity Index at 25: Origins, contributions and transitions","volume":"15","author":"McLellan","year":"2006","journal-title":"American Journal of Addiction"},{"key":"10.1016\/j.jsat.2014.07.006_bb0055","series-title":"The Addiction Severity Index\u2013\u201cLite\u201d","author":"McLellan","year":"1997"},{"key":"10.1016\/j.jsat.2014.07.006_bb9000","series-title":"Atypical Antipsychotic Abuse Experiences (AAAE), Unpublished measure","author":"Murray","year":"2013"},{"key":"10.1016\/j.jsat.2014.07.006_bb0065","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1176\/appi.ajp.161.9.1718","article-title":"Intranasal quetiapine abuse","volume":"161","author":"Pierre","year":"2004","journal-title":"American Journal of Psychiatry"},{"issue":"10","key":"10.1016\/j.jsat.2014.07.006_bb0070","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.4088\/JCP.v66n1011","article-title":"Reduction of opioid-withdrawal symptoms with quetiapine","volume":"66","author":"Pinkofsky","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jsat.2014.07.006_bb0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1176\/ajp.2007.164.1.174","article-title":"Quetiapine addiction?","volume":"164","author":"Pinta","year":"2007","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2014.07.006_bb0080","first-page":"13","article-title":"Is seroquel developing an illicit reputation for misuse\/abuse?","volume":"1","author":"Sansone","year":"2010","journal-title":"Psychiatry"},{"key":"10.1016\/j.jsat.2014.07.006_bb0085","series-title":"How young adults obtain prescription pain relievers for nonmedical use. (NSDUH Report, Issue 39)","author":"Substance Abuse and Mental Health Services Administration (SAMSA)","year":"2006"},{"key":"10.1016\/j.jsat.2014.07.006_bb0090","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1176\/ajp.2007.164.2.350","article-title":"Black-market value of antipsychotics, antidepressants, and hypnotics in Las Vegas, Nevada","volume":"164","author":"Tarasoff","year":"2007","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2014.07.006_bb0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1176\/ajp.2007.164.1.173a","article-title":"Intravenous quetiapine\u2013cocaine use (\u201cQ-ball\u201d)","volume":"164","author":"Waters","year":"2007","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1016\/j.jsat.2014.07.006_bb0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/08897077.2011.558448","article-title":"Quetiapine dependence and withdrawal: A case report","volume":"32","author":"Yargic","year":"2011","journal-title":"Substance Abuse"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547214001433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547214001433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:41:23Z","timestamp":1760038883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547214001433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0740547214001433"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2014.07.006","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Misuse of atypical antipsychotics in conjunction with alcohol and other drugs of abuse","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2014.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}